Biopharma – Page 4

Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion, Expanding Neuroscience Portfolio

8 months ago talkbio0Tagged Acquisition, Biopharma, Caplyta, Intra-Cellular Therapies, Johnson and Johnson, Lumateperone, M&A, Neuroscience discipline

Johnson & Johnson, Intra-Cellular Therapies, Acquisition, Neuroscience, Lumateperone, CAPLYTA, Biopharma, M&A

Celebrating Visionaries: Insights from the 2024 Fierce 50 Honorees

8 months ago talkbio0Tagged 2024, Advocacy, Biopharma, Fierce, Health Equity, healthcare innovation, honorees

Fierce 50, 2024 Honorees, Healthcare Innovation, Biopharma, Health Equity, Patient Advocacy

Biotech Industry’s Turbulent Year: Fierce Biotech’s Top 10 Most-Read Stories of 2024

8 months ago talkbio0Tagged Biopharma, biotech industry, J.P. Morgan Healthcare, M&A, rejections, shutdowns, trends qualifier, United States Food and Drug Administration

Biotech industry, layoffs, site shutdowns, FDA rejections, M&A deals, J.P. Morgan Healthcare Conference, biopharma trends

Javara Undergoes Restructuring, Lays Off Staff Amidst Industry-Wide Challenges

8 months ago talkbio0Tagged Biopharma, Clinical Research, Industry, Javara, restructuring

Javara, layoffs, restructuring, clinical research, biopharma industry challenges

Biopharma’s New Horizon: Industry Leaders Converge at JPM 2025

9 months ago talkbio0Tagged Biopharma, Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, Doudna, Drug Industry, Gene Modification, Health care facility, healthcare, Janet, Jennifer, JPM, Robert Nelsen, Woodcock

JPM 2025, Biopharma, Jennifer Doudna, Janet Woodcock, Robert Nelsen, Scott Gottlieb, Healthcare, Gene Editing, CRISPR, Pharmaceutical Industry, Biotechnology

Trump’s Re-Election: A Mixed Bag for Biopharma with M&A Upsides and Vaccine Concerns

9 months ago talkbio0Tagged Acquisitions, Administration occupational activities, Biopharma, Independence, Inflation, mergers, Policy, Transplant Registry Unified Management Program, United States Food and Drug Administration, Vaccines

Trump Administration, Biopharma, Mergers and Acquisitions, Vaccine Policy, Robert F. Kennedy Jr., FDA Independence, Inflation Reduction Act

Alligator Bioscience Slashes 70% of Workforce Due to Financial Strains

9 months ago talkbio0Tagged Alligators, Biopharma, Bioscience, Capital, constraints, Financial Stress, Industry, Staff

Alligator Bioscience, staff cuts, capital constraints, biopharma industry, financial challenges

Navigating JPM Week 2024: Insights and Opportunities in Biopharma

9 months ago talkbio0Tagged Biopharma, deal-making, Industry, Investments, IPOs, JPM, M&A, Network, regulatory, trends qualifier

JPM Week 2024, Biopharma, Industry Insights, Networking, Deal-making, Investment, M&A, IPOs, Regulatory Trends

Empowering Women in Life Sciences: 2024’s Trailblazers in Biopharma R&D

9 months ago talkbio0Tagged 2024, Biological Science Disciplines, Biopharma, Fiercest, Gender, Health care facility, innovation, R&D, Women

Women in Life Sciences, Biopharma R&D, 2024’s Fiercest Women, Gender Balance, Innovation in Healthcare

Healthcare Evolution 2025: AI, IRA, and GLP-1s Redefine the Industry

10 months ago talkbio0Tagged advancements, Aortic Valve Insufficiency, Biopharma, DNA Integration, Glucagon-Like Peptide 1, Health care facility, Healthcare technology, Impact food supplement, Ira (eukaryote), Pharmaceutical Industry Shifts, Telemedicine, trends qualifier, Value-Based Care

AI in Healthcare, IRA Impact on Biopharma, GLP-1 Medications, Healthcare Trends 2025, Value-Based Care, Telemedicine Integration, Pharmaceutical Industry Shifts, Healthcare Technology Advancements